Valeda® Light Therapy for Dry Age-Related Macular Degeneration
A non-invasive, FDA-authorized treatment designed to support retinal function and help slow progression of dry AMD
Dry age-related macular degeneration (AMD) is a progressive retinal condition that affects the macula, the part of the eye responsible for sharp, central vision. Over time, it can make everyday activities such as reading, driving, and recognizing faces increasingly difficult. Early diagnosis and proactive management are key to preserving vision for as long as possible.
At Empire State Retina, we are committed to offering advanced, evidence-based treatment options. The Valeda® Light Delivery System is an FDA-authorized, non-invasive therapy designed for patients with early to intermediate dry AMD. It represents a new approach aimed at supporting retinal health and visual function.
A New Approach to Dry AMD Management
Valeda® uses photobiomodulation (PBM), a process that delivers specific wavelengths of light to the retina. This light-based therapy is designed to stimulate cellular activity, support mitochondrial function, and help reduce oxidative stress and inflammation within retinal tissue.
Unlike injections or surgical procedures, Valeda® Light Therapy is painless, performed entirely in-office, and requires no downtime.
Treatment Experience
During each session, patients comfortably sit while the Valeda® device delivers controlled light therapy to the eyes.
- Treatment is typically administered over a series of sessions across several weeks
- Each session lasts only a few minutes
- No anesthesia, injections, or recovery period are required
- The procedure is generally well tolerated
Most patients find the treatment comfortable and convenient, making it easy to incorporate into their regular routine.
Clinical Perspective
Studies of Valeda® Light Therapy in patients with early to intermediate dry AMD have shown potential benefits, including:
- Improved visual function and contrast sensitivity
- Support for central vision used in daily tasks such as reading and facial recognition
- Slowing of disease progression in some patients
- Strengthening of retinal cellular health through photobiomodulation
While Valeda® is not a cure for macular degeneration, it offers a promising option for patients seeking to actively support retinal health before significant vision loss occurs.
Is Valeda® Right for You?
Valeda® Light Therapy may be appropriate for patients diagnosed with early to intermediate dry AMD who still maintain functional central vision. Your retina specialist at Empire State Retina can evaluate your condition and determine whether this treatment may be beneficial as part of your overall care plan.